We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+0.45%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$520M
AUM Growth
+$3.52M
Cap. Flow
+$20.7M
Cap. Flow %
3.98%
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$10.3M
2
TSVT
2seventy bio
TSVT
+$5.44M
3
VERA icon
Vera Therapeutics
VERA
+$4.63M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$4.57M
5
TMCI icon
Treace Medical Concepts
TMCI
+$4.38M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$8.88M
2
RCM
R1 RCM Inc. Common Stock
RCM
+$5.52M
3
IRTC icon
iRhythm Holdings
IRTC
+$4.01M
4
ARWR icon
Arrowhead Research
ARWR
+$3.87M
5
HQY icon
HealthEquity
HQY
+$3.67M

Sector Composition

Rank Sector Weight
1 Healthcare 95.06%
2 Industrials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
51
Replimune Group
REPL
$1B
$4.63M 0.89%
262,200
+65,700
+33% +$1.56M
TMO icon
52
Thermo Fisher Scientific
TMO
$213B
$4.59M 0.88%
7,965
– –
HALO icon
53
Halozyme
HALO
$9.76B
$4.48M 0.86%
117,400
-20,000
-15% -$938K
RAIN
54
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$4.24M 0.81%
484,928
+466,128
+2,479% +$4.31M
ZNTL icon
55
Zentalis Pharmaceuticals
ZNTL
$331M
$4.02M 0.77%
234,000
+33,000
+16% +$668K
SGEN
56
DELISTED
Seagen Inc. Common Stock
SGEN
$3.92M 0.75%
19,350
-20,840
-52% -$3.34M
IMGN
57
DELISTED
Immunogen Inc
IMGN
$3.85M 0.74%
1,001,444
+197,500
+25% +$842K
SILK
58
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3.74M 0.72%
95,589
+11,000
+13% +$538K
BIIB icon
59
Biogen
BIIB
$29.8B
$3.61M 0.69%
13,002
-350
-3% -$96.8K
ABT icon
60
Abbott
ABT
$185B
$3.57M 0.69%
35,248
+3,500
+11% +$370K
ARQT icon
61
Arcutis Biotherapeutics
ARQT
$3.24B
$3.49M 0.67%
317,152
+113,300
+56% +$1.64M
BMY icon
62
Bristol-Myers Squibb
BMY
$134B
$3.47M 0.67%
50,000
– –
OLMA icon
63
Olema Pharmaceuticals
OLMA
$985M
$3.46M 0.66%
995,909
-445,896
-31% -$1.82M
SRPT icon
64
Sarepta Therapeutics
SRPT
$1.68B
$3.41M 0.65%
24,710
+21,910
+783% +$2.84M
OM icon
65
Outset Medical
OM
$92.5M
$3.39M 0.65%
12,267
+2,934
+31% +$1.08M
XBI icon
66
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$3.3M 0.64%
43,353
+27,871
+180% +$2.31M
RCKT icon
67
Rocket Pharmaceuticals
RCKT
$372M
$3.27M 0.63%
190,790
– –
IQV icon
68
IQVIA
IQV
$38.4B
$3.24M 0.62%
16,300
+1,200
+8% +$256K
MDT icon
69
Medtronic
MDT
$111B
$3.23M 0.62%
40,051
+8,500
+27% +$693K
RLYB icon
70
Rallybio
RLYB
$84.6M
$3.15M 0.61%
68,992
-8,494
-11% -$439K
ALHC icon
71
Alignment Healthcare
ALHC
$3.02B
$3M 0.58%
471,000
-78,000
-14% -$744K
CYTK icon
72
Cytokinetics
CYTK
$10.4B
$2.95M 0.57%
83,850
+400
+0.5% +$16.3K
DHR icon
73
Danaher
DHR
$139B
$2.93M 0.56%
13,113
– –
MRNA icon
74
Moderna
MRNA
$21.9B
$2.72M 0.52%
17,718
– –
EW icon
75
Edwards Lifesciences
EW
$51.1B
$2.64M 0.51%
31,900
– –
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sectoral Asset Management held 129 positions worth $520M, up 0.68% from $517M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sectoral Asset Management deployed $20.7M of net new capital in Q1 2023, opening 9 new positions and adding to 50 existing holdings. Its largest new stake was Mineralys Therapeutics: 613,233 shares worth $9.6M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 95% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was R1 RCM Inc. Common Stock, an estimated $5.52M trimmed.

  • Sectoral Asset Management's largest Q1 2023 buy was Mineralys Therapeutics: 613,233 shares worth $9.6M.
  • Sectoral Asset Management added most to Shockwave Medical, Inc. Common Stock in Q1 2023, an estimated $4.57M increase.
  • Sectoral Asset Management's biggest Q1 2023 reduction was R1 RCM Inc. Common Stock, cutting an estimated $5.52M.
  • Sectoral Asset Management fully exited Exelixis in Q1 2023, selling an estimated $8.88M.
  • Sectoral Asset Management's ten largest holdings make up 24% of its $520M portfolio in Q1 2023.
  • Sectoral Asset Management opened 9 new positions and closed 11 in Q1 2023.
  • Sectoral Asset Management's portfolio value rose 0.68% quarter-over-quarter to $520M.

Based on Sectoral Asset Management's 13F filing for Q1 2023, filed 12 May 2023.